PROBIOTIX HEALTH LS-05 (X90) — Cash Flow-to-Debt Ratio
PROBIOTIX HEALTH LS-05 (X90) has a Cash Flow-to-Debt Ratio of -4.17x as of December 2024, meaning its operating cash flow of €-1.06 Million could theoretically repay -4% of its total liabilities (€254.00K) in one year. See how liquid is PROBIOTIX HEALTH LS-05's working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PROBIOTIX HEALTH LS-05 Cash Flow-to-Debt Ratio (2022–2024)
Historical debt coverage capacity for PROBIOTIX HEALTH LS-05 across 3 annual periods. Also explore PROBIOTIX HEALTH LS-05 (X90) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for PROBIOTIX HEALTH LS-05 (2022–2024)
Year-by-year debt coverage analysis for PROBIOTIX HEALTH LS-05. For market capitalisation and broader financial context, see PROBIOTIX HEALTH LS-05 market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.17x | €-1.06 Million | €254.00K | ▼ -1024.0% |
| 2023 | -0.37x | €-238.00K | €641.00K | ▲ +79.6% |
| 2022 | -1.82x | €-638.02K | €350.91K | — |